Wednesday, March 20, 2019 9:13:53 PM
(Bloomberg) -- Tilray Inc. shares rose in post-market trading after the company reported revenue that beat estimates and a higher average selling price, though investor enthusiasm was dampened by weaker margins and a wider-than-expected loss.
The cannabis producer’s fourth-quarter revenue was $15.5 million, triple the year-ago period and ahead of the average analyst estimate of $15.1 million, as it sold more pot at higher prices. However, it lost $31 million in the quarter, significantly more than the $3 million lost a year earlier, amid higher operating expenses.
Key Insights
Tilray reported an average net selling price per gram of $7.52, up from $6.21 in the prior quarter and $7.13 a year ago. By comparison, Aurora Cannabis Inc.’s average selling price fell 26 percent for dried cannabis and 18 percent for cannabis extracts in the final quarter of the yearCost of sales rose to $12.4 million from $2.2 million a year earlier, the result of higher operating expenses related to growth initiatives, expansion of international teams, and financings and M&A activity, the company saidGross margins fell to 20 percent from 57 percent a year earlier as a result of costs related to securing cannabis supply from third parties, ramping up production and absorbing the tax for medical patients, Chief Financial Officer Mark Castaneda said on the company’s earnings call. He expects gross margins to rise back above 50 percent in the longer termTilray sold 2,053 kilograms of cannabis, up from 1,613 kilograms in the third quarter
Management Commentary
Recreational marijuana sales accounted for about 30 percent of total revenue, Chief Executive Officer Brendan Kennedy said in an interview“Originally we were projecting it to grow to be 40 to 50 percent of our revenue for this year and we think it’ll actually be less than that, not because the numbers are smaller, but because revenue from other sources is actually going to be larger than we thought,” Kennedy saidThose other sources include Tilray’s acquisition of Manitoba Harvest, higher global medical sales and projected revenue from CBD wellness products in the U.S.Tilray doesn’t see much opportunity to do deals in Canada“The United States and European markets are orders of magnitude larger than Canada, so while Canada will continue to be an important market for us, we expect to focus the majority of future investments on the U.S. and Europe,” Kennedy said on the earnings call. “We will not purchase or invest in what we believe to be overpriced supply assets in Canada, which we believe will erode in value in the medium- to long-term as the market normalizes”Kennedy believes “we are a lot closer to federal legalization in the U.S. than most people realize”He also sees the number of countries with legal medical markets rising to 50 or 60 by the end of 2019 from 41 at the end of 2018
(Adds gross margin in 3rd bullet point, adds management commentary section.)
To contact the reporter on this story: Kristine Owram in Toronto at kowram@bloomberg.net
Recent VFF News
- Village Farms International to Report Q1/24 Results on May 8, 2024 • GlobeNewswire Inc. • 04/26/2024 11:00:00 AM
- Village Farms International Expands Executive Team • GlobeNewswire Inc. • 04/24/2024 11:00:00 AM
- A category innovation: Pure Sunfarms introduces Hi-Def Pre-Rolls • GlobeNewswire Inc. • 04/18/2024 11:00:00 AM
- Village Farms International Comments on Canadian Budget • GlobeNewswire Inc. • 04/17/2024 11:00:00 AM
- Village Farms International Posts Eight Consecutive Months of National Share Growth • GlobeNewswire Inc. • 04/11/2024 11:00:00 AM
- Village Farms International Appoints William Stoufer as President, Balanced Health Botanicals • GlobeNewswire Inc. • 04/10/2024 09:00:00 PM
- Village Farms International Regains Nasdaq Compliance • GlobeNewswire Inc. • 04/09/2024 02:08:11 PM
- Village Farms International Named Fastest Growing Cannabis Company by Financial Times ‘Americas’ • GlobeNewswire Inc. • 04/05/2024 11:00:00 AM
- Village Farms International Announces Start Up of Renewable Natural Gas Facility • GlobeNewswire Inc. • 04/03/2024 11:00:00 AM
- Village Farms International Applauds German Cannabis Progress • GlobeNewswire Inc. • 03/22/2024 07:30:00 PM
- Mixed Futures Amidst Quiet Economic Schedule; Oil Prices Climb • IH Market News • 03/13/2024 11:03:39 AM
- Village Farms International Reports Q4 and 2023 Financials: Record Consolidated Sales for Q4 • GlobeNewswire Inc. • 03/13/2024 11:00:00 AM
- Village Farms International Enthusiastically Supports Standing Committee’s Recommendations for New Cannabis Excise Duty Model • GlobeNewswire Inc. • 02/29/2024 03:40:00 PM
- Pure Sunfarms’ Bigger Better Buds Inspire New Design • GlobeNewswire Inc. • 02/22/2024 03:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/20/2024 01:50:39 PM
- Village Farms International to Report Fourth Quarter and Year End 2023 Financial Results on Wednesday, March 13, 2024 at 7:00 a.m. ET / Conference Call to be Held Same Day at 8:30 a.m. ET • GlobeNewswire Inc. • 02/20/2024 12:00:00 PM
- Village Farms International Receives Outstanding Employer Award • GlobeNewswire Inc. • 02/05/2024 12:00:00 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 01/31/2024 09:48:48 PM
- Village Farms International Commences Build-Out of Netherlands Cannabis Facility • GlobeNewswire Inc. • 01/31/2024 12:00:00 PM
- Village Farms International Announces Launch of Top-Selling Cannabis Brands in the UK • GlobeNewswire Inc. • 01/03/2024 12:00:00 PM
- Village Farms International to Participate in Zuanic and Associates Panel • GlobeNewswire Inc. • 12/05/2023 12:00:00 PM
- Village Farms Fresh Produce Gives Back to Texan Veteran with Military Makeover • GlobeNewswire Inc. • 11/17/2023 01:30:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/08/2023 12:05:27 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/08/2023 12:02:09 PM
- Village Farms International Reports Strong Third Quarter Results, Highlighted by Positive Cash Generation from Each Operating Segment • GlobeNewswire Inc. • 11/08/2023 12:00:00 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM